FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093140245> ?p ?o ?g. }

• W3093140245 abstract "Abstract Background Endogenous apoliloprotein E mediates neuroinflammatory responses and recovery after brain injury. Exogenously administered apolipoprotein E-mimetic peptides can effectively penetrate the brain and down-regulate acute inflammation. CN-105 is a novel apolipoprotein E-mimetic pentapeptide with excellent preclinical evidence as an acute intracerebral hemorrhage (ICH) therapeutic. The C N-105 in participants with A cute supra T entorial intra C erebral H emorrhage (CATCH) trial is a first-in-disease-state, multi-center, open-label trial evaluating safety and feasability of CN-105 administration in patients with acute primary supratentorial ICH. Methods Eligible patients were age 30-80 years, had confirmed primary supratentorial ICH, and able to intiate CN-105 administration (1.0 mg/kg every 6 hours for 72 hours) within 12 hours of symptom onset. A priori defined safety endpoints, including hematoma volume, pharmacokinetics, and 30-day neurological outcomes were analyzed. For comparisons, CATCH participants were matched 1:1 with a contemporary ICH cohort through random selection. Hematoma volumes determined from computed tomography images on Days 0, 1, 2, and 5 and ordinal modified Rankin Score at 30 days after ICH were compared. Results In 39 participants enrolled across six study sites in the United States, adverse events occurred at expected rate without increase in hematoma expansion or neurological deterioration or significant serum accumulation. CN-105 treatment had an odds ratio (95% confidence interval) of 2.69 (1.31–5.51) for lower 30-day mRS, after adjustment for ICH Score, sex, and race/ethnicity, compared to matched contemporary cohort. Conclusion CN-105 administration represents an excellent translational candidate as an actue ICH therapeutic due to its safety, dosing feasibility, favorable pharmacokinetics, and evidence of improved neurological recovery." @default.
• W3093140245 created "2020-10-22" @default.
• W3093140245 creator A5002498224 @default.
• W3093140245 creator A5009653243 @default.
• W3093140245 creator A5010722813 @default.
• W3093140245 creator A5024993569 @default.
• W3093140245 creator A5026116104 @default.
• W3093140245 creator A5026485252 @default.
• W3093140245 creator A5027278803 @default.
• W3093140245 creator A5031381266 @default.
• W3093140245 creator A5037076906 @default.
• W3093140245 creator A5049174056 @default.
• W3093140245 creator A5064334744 @default.
• W3093140245 creator A5085604291 @default.
• W3093140245 creator A5088379828 @default.
• W3093140245 creator A5089497208 @default.
• W3093140245 creator A5091314623 @default.
• W3093140245 date "2020-10-15" @default.
• W3093140245 modified "2023-10-17" @default.
• W3093140245 title "CN-105 in Participants with Acute SupraTentorial IntraCerebral Hemorrhage (CATCH) Trial" @default.
• W3093140245 cites W1755360319 @default.
• W3093140245 cites W185304927 @default.
• W3093140245 cites W1947113872 @default.
• W3093140245 cites W1965252003 @default.
• W3093140245 cites W1981344227 @default.
• W3093140245 cites W1993054804 @default.
• W3093140245 cites W1994990224 @default.
• W3093140245 cites W1998007306 @default.
• W3093140245 cites W2001079198 @default.
• W3093140245 cites W2001201410 @default.
• W3093140245 cites W2005052178 @default.
• W3093140245 cites W2010365051 @default.
• W3093140245 cites W2025513910 @default.
• W3093140245 cites W2027278399 @default.
• W3093140245 cites W2029534598 @default.
• W3093140245 cites W2029616852 @default.
• W3093140245 cites W2034949801 @default.
• W3093140245 cites W2040324263 @default.
• W3093140245 cites W2045663319 @default.
• W3093140245 cites W2058120050 @default.
• W3093140245 cites W2067854253 @default.
• W3093140245 cites W2075522885 @default.
• W3093140245 cites W2080378222 @default.
• W3093140245 cites W2112624512 @default.
• W3093140245 cites W2113711307 @default.
• W3093140245 cites W2114214167 @default.
• W3093140245 cites W2118775574 @default.
• W3093140245 cites W2132862382 @default.
• W3093140245 cites W2136097616 @default.
• W3093140245 cites W2142640478 @default.
• W3093140245 cites W2155602214 @default.
• W3093140245 cites W2157727193 @default.
• W3093140245 cites W2168934316 @default.
• W3093140245 cites W2203742140 @default.
• W3093140245 cites W2318993527 @default.
• W3093140245 cites W2359884680 @default.
• W3093140245 cites W2394500798 @default.
• W3093140245 cites W2409181187 @default.
• W3093140245 cites W2528399692 @default.
• W3093140245 cites W2563311768 @default.
• W3093140245 cites W2593726173 @default.
• W3093140245 cites W2605714883 @default.
• W3093140245 cites W2802348543 @default.
• W3093140245 cites W2804714053 @default.
• W3093140245 cites W2890394490 @default.
• W3093140245 cites W2891595683 @default.
• W3093140245 cites W2891611151 @default.
• W3093140245 cites W2914368780 @default.
• W3093140245 cites W2921259698 @default.
• W3093140245 cites W3003733049 @default.
• W3093140245 cites W3016600470 @default.
• W3093140245 doi "https://doi.org/10.1101/2020.10.13.20211417" @default.
• W3093140245 hasPublicationYear "2020" @default.
• W3093140245 type Work @default.
• W3093140245 sameAs 3093140245 @default.
• W3093140245 citedByCount "0" @default.
• W3093140245 crossrefType "posted-content" @default.
• W3093140245 hasAuthorship W3093140245A5002498224 @default.
• W3093140245 hasAuthorship W3093140245A5009653243 @default.
• W3093140245 hasAuthorship W3093140245A5010722813 @default.
• W3093140245 hasAuthorship W3093140245A5024993569 @default.
• W3093140245 hasAuthorship W3093140245A5026116104 @default.
• W3093140245 hasAuthorship W3093140245A5026485252 @default.
• W3093140245 hasAuthorship W3093140245A5027278803 @default.
• W3093140245 hasAuthorship W3093140245A5031381266 @default.
• W3093140245 hasAuthorship W3093140245A5037076906 @default.
• W3093140245 hasAuthorship W3093140245A5049174056 @default.
• W3093140245 hasAuthorship W3093140245A5064334744 @default.
• W3093140245 hasAuthorship W3093140245A5085604291 @default.
• W3093140245 hasAuthorship W3093140245A5088379828 @default.
• W3093140245 hasAuthorship W3093140245A5089497208 @default.
• W3093140245 hasAuthorship W3093140245A5091314623 @default.
• W3093140245 hasBestOaLocation W30931402451 @default.
• W3093140245 hasConcept C126322002 @default.
• W3093140245 hasConcept C141071460 @default.
• W3093140245 hasConcept C156957248 @default.
• W3093140245 hasConcept C168563851 @default.
• W3093140245 hasConcept C203092338 @default.
• W3093140245 hasConcept C2777094939 @default.
• W3093140245 hasConcept C2777736543 @default.

• next